Don't forget folks that the price Paradigm will receive will be...

Don't forget folks that the price Paradigm will receive will be markedly different to the price paid at the chemist!
Once a drug is approved to be on the Pharmaceutical Benefits Scheme there is a price agreement process between the 2 parties to determine how much it will be subsidised by the PBS...Obviously PAR has a pretty good argument for cost-benefit, not only avoiding joint replacements down the road, but also reducing arthroscopies in the short term, not to mention cost savings on other anti-inflammatories/opioids, plus the potential productivity in not losing these people from the workforce....
I agree that patients are probably not going to front up with $2000 for their course of pentosan, but they may well pay $200 or so, while the PBS quietly pays the other $1800 that you don't see!